rna结合蛋白、gadd45 - α、p27Kip1、p53和基因毒性应激反应与癌症化疗耐药的关系

Molecular and cellular pharmacology Pub Date : 2015-01-01
M Saeed Sheikh
{"title":"rna结合蛋白、gadd45 - α、p27Kip1、p53和基因毒性应激反应与癌症化疗耐药的关系","authors":"M Saeed Sheikh","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Genotoxic chemotherapeutics particularly cisplatin remain effective for clinical management of various malignancies including lung cancer. However, the development of chemoresistance leads to treatment failure. The mechanisms by which tumor cells acquire resistance to chemotherapy are multifaceted in nature and some remain to be fully elucidated. Recently, a potential role of RNA-binding protein hnRNPA0 in chemoresistance of p53-defective lung cancer cells was reported. Genotoxic (DNA damaging) chemotherapy was reported to activate hnRNPA0 which in turn post-transcriptionally regulated p27<sup>Kip1</sup> and Gadd45-alpha by stabilizing their mRNAs. Regulation of p27<sup>Kip1</sup> and Gadd45-alpha led to enforcement of G1/S and G2/M checkpoints thereby providing time for DNA repair and thus, resistance to chemotherapy. The identification of a signaling network involving the kinase MK2, hnRNPA0, p27<sup>Kip1</sup> and Gadd45-alpha that may predict response to chemotherapy is an interesting finding. Further studies are now needed to gain additional insights as to whether this network is restricted only to a subset of tumors or more broadly relevant across multiple tumor types.</p>","PeriodicalId":18748,"journal":{"name":"Molecular and cellular pharmacology","volume":"7 3","pages":"41-45"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824310/pdf/nihms-761602.pdf","citationCount":"0","resultStr":"{\"title\":\"RNA-binding Protein, GADD45-alpha, p27<sup>Kip1</sup>, p53 and Genotoxic Stress Response in Relation to Chemoresistance in Cancer.\",\"authors\":\"M Saeed Sheikh\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Genotoxic chemotherapeutics particularly cisplatin remain effective for clinical management of various malignancies including lung cancer. However, the development of chemoresistance leads to treatment failure. The mechanisms by which tumor cells acquire resistance to chemotherapy are multifaceted in nature and some remain to be fully elucidated. Recently, a potential role of RNA-binding protein hnRNPA0 in chemoresistance of p53-defective lung cancer cells was reported. Genotoxic (DNA damaging) chemotherapy was reported to activate hnRNPA0 which in turn post-transcriptionally regulated p27<sup>Kip1</sup> and Gadd45-alpha by stabilizing their mRNAs. Regulation of p27<sup>Kip1</sup> and Gadd45-alpha led to enforcement of G1/S and G2/M checkpoints thereby providing time for DNA repair and thus, resistance to chemotherapy. The identification of a signaling network involving the kinase MK2, hnRNPA0, p27<sup>Kip1</sup> and Gadd45-alpha that may predict response to chemotherapy is an interesting finding. Further studies are now needed to gain additional insights as to whether this network is restricted only to a subset of tumors or more broadly relevant across multiple tumor types.</p>\",\"PeriodicalId\":18748,\"journal\":{\"name\":\"Molecular and cellular pharmacology\",\"volume\":\"7 3\",\"pages\":\"41-45\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824310/pdf/nihms-761602.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular and cellular pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and cellular pharmacology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

基因毒性化疗特别是顺铂在包括肺癌在内的各种恶性肿瘤的临床治疗中仍然有效。然而,化疗耐药的发展导致治疗失败。肿瘤细胞获得化疗耐药的机制在本质上是多方面的,其中一些仍有待充分阐明。最近,rna结合蛋白hnRNPA0在p53缺陷肺癌细胞化疗耐药中的潜在作用被报道。据报道,基因毒性(DNA损伤)化疗可激活hnRNPA0, hnRNPA0反过来通过稳定p27Kip1和gadd45 - α的mrna来转录后调节p27Kip1和gadd45 - α。p27Kip1和Gadd45-alpha的调控导致G1/S和G2/M检查点的执行,从而为DNA修复提供时间,从而对化疗产生抗性。发现涉及激酶MK2、hnRNPA0、p27Kip1和gadd45 - α的信号网络可能预测化疗反应是一个有趣的发现。现在需要进一步的研究来获得更多的见解,以确定该网络是否仅局限于肿瘤的一个子集,还是在多种肿瘤类型中更广泛地相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
RNA-binding Protein, GADD45-alpha, p27Kip1, p53 and Genotoxic Stress Response in Relation to Chemoresistance in Cancer.

Genotoxic chemotherapeutics particularly cisplatin remain effective for clinical management of various malignancies including lung cancer. However, the development of chemoresistance leads to treatment failure. The mechanisms by which tumor cells acquire resistance to chemotherapy are multifaceted in nature and some remain to be fully elucidated. Recently, a potential role of RNA-binding protein hnRNPA0 in chemoresistance of p53-defective lung cancer cells was reported. Genotoxic (DNA damaging) chemotherapy was reported to activate hnRNPA0 which in turn post-transcriptionally regulated p27Kip1 and Gadd45-alpha by stabilizing their mRNAs. Regulation of p27Kip1 and Gadd45-alpha led to enforcement of G1/S and G2/M checkpoints thereby providing time for DNA repair and thus, resistance to chemotherapy. The identification of a signaling network involving the kinase MK2, hnRNPA0, p27Kip1 and Gadd45-alpha that may predict response to chemotherapy is an interesting finding. Further studies are now needed to gain additional insights as to whether this network is restricted only to a subset of tumors or more broadly relevant across multiple tumor types.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
0
期刊最新文献
Sacituzumab govitecan for hormone receptor-positive and triple-negative breast cancers. Protein Kinase D: A Potential Therapeutic Target in Prostate Cancer. RNA-binding Protein, GADD45-alpha, p27Kip1, p53 and Genotoxic Stress Response in Relation to Chemoresistance in Cancer. mTOR Inhibitors at a Glance. Curcumin-encapsulating Nanogels as an Effective Anticancer Formulation for Intracellular Uptake.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1